Recall Z-0945-2022

Acon Biotech (Hangzhou) Co., Ltd. · initiated January 9, 2022

Class II Open, Classified

Class II – products that might cause a temporary health problem or pose a slight threat of a serious nature

Product

Flowflex SARS-CoV-2 Antigen Rapid Test (Self-Testing), CE marked

Codes / lots: Lots: COV1080201, COV1105014

Reason for recall

Non-EUA authorized, CE marked, SARS-CoV-2 antigen rapid test kits are being recalled from the U.S. market because use may lead to inaccurate test results, including false negative or false positive test results.

FDA-determined cause: No Marketing Application

Action taken

On 04/04/22, recall notices were sent to distributor customers who were asked to do the following: If you may have further distributed this product, please identify your customers and notify them at once of this product correction. Your notification to your customers may be enhanced by including a copy of this correction notification letter. This correction should be carried out to the consumer/user level in U.S. Complete and return the response form to the recalling firm. Customers with additional questions were encouraged to contact Denice Dong, Denice.Dong@aconlab.com.cn Additional instructions in a press release were provided to address affected non-EUA devices, of unknown quantity, that may have entered the U.S. market. It is recommended to stop use and dispose of affected devices in the U.S. market: https://www.aconlabs.com/news/

Details

Recall number
Z-0945-2022
Initiated
January 9, 2022
Product code
QKP – Coronavirus Antigen Detection Test System.
Quantity
303,760
Distribution
US: MD, PA International Distribution to countries of: Hungary and China.
Recalling firm
Acon Biotech (Hangzhou) Co., Ltd., Hangzhou

Official FDA recall record